METHYLPHENIDATE

METHYLPHENIDATE was reported 58050 times

These side effects are most commonly reported by patients taking METHYLPHENIDATE:

# Side effect Count
0 NO ADVERSE EVENT 6896
1 OFF LABEL USE 5959
2 PRODUCT QUALITY ISSUE 5247
3 DRUG INEFFECTIVE 2929
4 DRUG ADMINISTRATION ERROR 1901
5 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1772
6 APPLICATION SITE ERYTHEMA 1699
7 DRUG DOSE OMISSION 1478
8 INCORRECT DRUG ADMINISTRATION DURATION 1191
9 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1157
10 DRUG PRESCRIBING ERROR 1079
11 DISTURBANCE IN ATTENTION 916
12 PRODUCT ADHESION ISSUE 896
13 ANXIETY 868
14 FATIGUE 866
15 HEADACHE 846
16 NAUSEA 832
17 DECREASED APPETITE 815
18 APPLICATION SITE PRURITUS 812
19 INSOMNIA 746
20 TOXICITY TO VARIOUS AGENTS 691
21 DRUG ADMINISTERED AT INAPPROPRIATE SITE 680
22 APPLICATION SITE IRRITATION 659
23 DEPRESSION 641
24 AGGRESSION 600
25 SOMNOLENCE 574
26 CONDITION AGGRAVATED 557
27 DIZZINESS 546
28 VOMITING 530
29 PSYCHOMOTOR HYPERACTIVITY 524
30 WEIGHT DECREASED 513
31 ABNORMAL BEHAVIOUR 463
32 AGITATION 463
33 APPLICATION SITE PAIN 461
34 DISTURBANCE IN SOCIAL BEHAVIOUR 452
35 OVERDOSE 447
36 SUICIDAL IDEATION 440
37 PRODUCT SUBSTITUTION ISSUE 437
38 FEELING ABNORMAL 432
39 DRUG ABUSE 420
40 DEVICE DIFFICULT TO USE 415
41 HYPERTENSION 402
42 PAIN 401
43 DRUG INTERACTION 397
44 PRODUCT ADMINISTRATION ERROR 397
45 IRRITABILITY 376
46 MALAISE 358
47 DIARRHOEA 356
48 RASH 356
49 FALL 351
50 TACHYCARDIA 342
51 APPLICATION SITE RASH 337
52 WEIGHT INCREASED 330
53 PRODUCT DOSE OMISSION ISSUE 323
54 DYSPNOEA 314
55 TREMOR 314
56 DEVICE ADHESION ISSUE 304
57 PRURITUS 293
58 COMPLETED SUICIDE 285
59 ASTHENIA 270
60 HYPERHIDROSIS 270
61 DEVICE BREAKAGE 263
62 CONFUSIONAL STATE 247
63 THERAPY CESSATION 246
64 DRUG EFFECT DECREASED 243
65 ABDOMINAL PAIN UPPER 238
66 INTENTIONAL OVERDOSE 235
67 MEMORY IMPAIRMENT 233
68 BLOOD PRESSURE INCREASED 229
69 DEATH 226
70 PNEUMONIA 225
71 ANGER 222
72 PRESCRIBED OVERDOSE 221
73 PYREXIA 221
74 DEVICE ISSUE 217
75 ARTHRALGIA 216
76 PALPITATIONS 214
77 DEPRESSED MOOD 213
78 SUICIDE ATTEMPT 213
79 DYSKINESIA 209
80 INTENTIONAL PRODUCT MISUSE 208
81 SLEEP APNOEA SYNDROME 207
82 MUSCLE SPASMS 205
83 HYPERSENSITIVITY 204
84 INTENTIONAL PRODUCT USE ISSUE 202
85 MIGRAINE 201
86 INCORRECT DOSE ADMINISTERED 200
87 SEIZURE 198
88 HALLUCINATION 194
89 ACCIDENTAL EXPOSURE TO PRODUCT 193
90 GAIT DISTURBANCE 193
91 TIC 191
92 CRYING 190
93 PAIN IN EXTREMITY 186
94 THERAPEUTIC RESPONSE UNEXPECTED 185
95 SURGERY 184
96 CHEST PAIN 183
97 CONSTIPATION 181
98 EDUCATIONAL PROBLEM 181
99 LOSS OF CONSCIOUSNESS 181
100 SLEEP DISORDER 181
101 TREATMENT NONCOMPLIANCE 181
102 COUGH 179
103 PRODUCT USE ISSUE 179
104 DRUG DEPENDENCE 178
105 NASOPHARYNGITIS 178
106 HEART RATE INCREASED 175
107 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 172
108 ABDOMINAL DISCOMFORT 170
109 APPLICATION SITE SWELLING 168
110 PRODUCT USE IN UNAPPROVED INDICATION 166
111 PARAESTHESIA 164
112 ABDOMINAL PAIN 159
113 BACK PAIN 159
114 RESTLESSNESS 158
115 WITHDRAWAL SYNDROME 158
116 HYPOAESTHESIA 157
117 PANIC ATTACK 153
118 PSYCHOTIC DISORDER 148
119 SINUSITIS 148
120 URTICARIA 148
121 VISION BLURRED 148
122 COVID-19 147
123 SEROTONIN SYNDROME 146
124 PRODUCT ADMINISTRATION INTERRUPTED 144
125 HYPOTENSION 143
126 PRE-EXISTING CONDITION IMPROVED 142
127 ADHESIVE TAPE USE 141
128 APPLICATION SITE URTICARIA 140
129 DRUG HYPERSENSITIVITY 138
130 IMPULSIVE BEHAVIOUR 133
131 FOETAL EXPOSURE DURING PREGNANCY 130
132 ILLNESS 130
133 MOOD SWINGS 128
134 THERAPEUTIC PRODUCT INEFFECTIVE 128
135 ERYTHEMA 127
136 GASTROOESOPHAGEAL REFLUX DISEASE 126
137 UNEVALUABLE EVENT 126
138 DRY MOUTH 125
139 STRESS 125
140 ALOPECIA 124
141 URINARY TRACT INFECTION 124
142 EMOTIONAL DISORDER 123
143 LETHARGY 121
144 MUSCULAR WEAKNESS 119
145 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 119
146 HALLUCINATION, VISUAL 118
147 INCORRECT STORAGE OF DRUG 118
148 INCREASED APPETITE 118
149 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 116
150 CARDIAC ARREST 115
151 CARDIO-RESPIRATORY ARREST 115
152 DYSTONIA 115
153 TREATMENT FAILURE 115
154 DRUG EFFECT DELAYED 114
155 SEDATION 111
156 APPLICATION SITE DISCOLOURATION 110
157 ELECTROCARDIOGRAM QT PROLONGED 107
158 ASTHMA 106
159 HOSPITALISATION 106
160 PARANOIA 106
161 DRUG WITHDRAWAL SYNDROME 105
162 DRUG INTOLERANCE 104
163 INTENTIONAL SELF-INJURY 104
164 LOGORRHOEA 104
165 APPLICATION SITE VESICLES 103
166 BALANCE DISORDER 103
167 AMNESIA 99
168 DRUG EFFECT INCREASED 99
169 FLUSHING 99
170 GASTROINTESTINAL DISORDER 99
171 MOOD ALTERED 99
172 MYALGIA 99
173 NERVOUSNESS 99
174 VISUAL IMPAIRMENT 99
175 APPLICATION SITE DRYNESS 98
176 DEHYDRATION 98
177 ACCIDENTAL EXPOSURE 97
178 POISONING 96
179 INFECTION 93
180 MYDRIASIS 93
181 EMOTIONAL DISTRESS 89
182 ENURESIS 89
183 THERAPEUTIC PRODUCT EFFECT DECREASED 89
184 INFLUENZA 88
185 MENTAL DISORDER 88
186 DYSPEPSIA 87
187 INITIAL INSOMNIA 87
188 ACUTE KIDNEY INJURY 86
189 MULTIPLE SCLEROSIS RELAPSE 86
190 SPEECH DISORDER 86
191 EXPOSURE DURING PREGNANCY 85
192 INJECTION SITE PAIN 85
193 NIGHTMARE 83
194 PRODUCT INEFFECTIVE 83
195 UNRESPONSIVE TO STIMULI 83
196 APPLICATION SITE BURN 82
197 PRODUCT DOSE OMISSION 81
198 COGNITIVE DISORDER 80
199 THERAPEUTIC RESPONSE DECREASED 80
200 ADVERSE DRUG REACTION 79
201 DEPRESSED LEVEL OF CONSCIOUSNESS 79
202 FEELING JITTERY 79
203 MANIA 79
204 SYNCOPE 79
205 AFFECT LABILITY 78
206 PERIPHERAL SWELLING 78
207 URINARY INCONTINENCE 78
208 DYSPHAGIA 77
209 CHEST DISCOMFORT 76
210 MYOCARDIAL INFARCTION 76
211 PRODUCT AVAILABILITY ISSUE 76
212 CONTUSION 75
213 HALLUCINATION, AUDITORY 75
214 MUSCLE TWITCHING 75
215 NEPHROLITHIASIS 75
216 INTENTIONAL DOSE OMISSION 74
217 ATTENTION DEFICIT HYPERACTIVITY DISORDER 73
218 BRONCHITIS 73
219 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 73
220 CEREBROVASCULAR ACCIDENT 72
221 DRY SKIN 72
222 SOMNAMBULISM 72
223 CHRONIC KIDNEY DISEASE 71
224 DISCOMFORT 71
225 APATHY 70
226 CHILLS 70
227 NEUROPATHY PERIPHERAL 70
228 OROPHARYNGEAL PAIN 69
229 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 68
230 RESTLESS LEGS SYNDROME 68
231 CONVULSION 67
232 ANAEMIA 66
233 PULMONARY EMBOLISM 66
234 BODY TEMPERATURE INCREASED 65
235 CATAPLEXY 65
236 SKIN IRRITATION 65
237 APPLICATION SITE EXFOLIATION 64
238 CARDIAC VALVE DISEASE 64
239 COMA 64
240 INCORRECT PRODUCT STORAGE 64
241 RENAL FAILURE 64
242 THERAPEUTIC RESPONSE SHORTENED 64
243 DELUSION 63
244 FEELING HOT 63
245 HEPATIC ENZYME INCREASED 63
246 HYPOTHYROIDISM 62
247 BRADYCARDIA 61
248 MEDICATION ERROR 61
249 TARDIVE DYSKINESIA 61
250 THERAPY NON-RESPONDER 61
251 ABDOMINAL DISTENSION 60
252 APPLICATION SITE EROSION 60
253 HYPERSOMNIA 60
254 ADVERSE EVENT 59
255 NECK PAIN 59
256 OBSESSIVE-COMPULSIVE DISORDER 59
257 HYPERKINESIA 58
258 PRODUCT STORAGE ERROR 58
259 ARRHYTHMIA 57
260 DRY EYE 57
261 POOR QUALITY SLEEP 57
262 PULMONARY MALFORMATION 57
263 ROAD TRAFFIC ACCIDENT 57
264 SWELLING 57
265 AKATHISIA 56
266 DERMATITIS CONTACT 56
267 DRUG USE DISORDER 56
268 VERTIGO 56
269 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 55
270 MATERNAL EXPOSURE DURING BREAST FEEDING 55
271 ATTENTION DEFICIT/HYPERACTIVITY DISORDER 54
272 DIABETES MELLITUS 54
273 DRUG EFFECT LESS THAN EXPECTED 54
274 HUNGER 54
275 SEASONAL ALLERGY 54
276 TINNITUS 54
277 ARTERIOSCLEROSIS CORONARY ARTERY 53
278 BLOOD CREATINE PHOSPHOKINASE INCREASED 53
279 DRUG LEVEL INCREASED 53
280 EPISTAXIS 53
281 EXTRAPYRAMIDAL DISORDER 53
282 MULTIPLE SCLEROSIS 53
283 DISORIENTATION 52
284 ECZEMA 52
285 GYNAECOMASTIA 52
286 MENTAL IMPAIRMENT 52
287 NASAL CONGESTION 52
288 NEUTROPENIA 52
289 POLLAKIURIA 52
290 ABNORMAL DREAMS 51
291 ACNE 51
292 HOT FLUSH 51
293 MIDDLE INSOMNIA 51
294 MUSCULOSKELETAL STIFFNESS 51
295 NIGHT SWEATS 51
296 RHABDOMYOLYSIS 51
297 APPLICATION SITE REACTION 50
298 APPLICATION SITE SCAB 50
299 CATARACT 50
300 DRUG DOSE OMISSION BY DEVICE 50
301 FEAR 50
302 GENERALISED TONIC-CLONIC SEIZURE 50
303 OEDEMA PERIPHERAL 50
304 SEPSIS 50
305 BLOOD GLUCOSE INCREASED 49
306 DYSGEUSIA 49
307 FOOT FRACTURE 49
308 RHINORRHOEA 49
309 SKIN EXFOLIATION 49
310 ALANINE AMINOTRANSFERASE INCREASED 48
311 BLOOD CHOLESTEROL INCREASED 48
312 DRUG-INDUCED LIVER INJURY 48
313 FIBROMYALGIA 48
314 DERMATITIS ATOPIC 47
315 PULMONARY OEDEMA 47
316 ARTHRITIS 46
317 ATRIAL FIBRILLATION 46
318 MATERNAL EXPOSURE DURING PREGNANCY 46
319 PNEUMONIA ASPIRATION 46
320 RHEUMATOID ARTHRITIS 46
321 DRUG DIVERSION 45
322 EXPIRED PRODUCT ADMINISTERED 45
323 MOVEMENT DISORDER 45
324 RESPIRATORY ARREST 45
325 THROMBOSIS 45
326 WHITE BLOOD CELL COUNT DECREASED 45
327 ACUTE MYOCARDIAL INFARCTION 44
328 ASPARTATE AMINOTRANSFERASE INCREASED 44
329 DELIRIUM 44
330 DRUG TOLERANCE 44
331 EXPOSURE VIA BREAST MILK 44
332 SCREAMING 44
333 SINUS TACHYCARDIA 44
334 THIRST 44
335 URINARY RETENTION 44
336 DEEP VEIN THROMBOSIS 43
337 MOBILITY DECREASED 43
338 SUBSTANCE ABUSE 43
339 SWELLING FACE 43
340 TRISMUS 43
341 ALTERED STATE OF CONSCIOUSNESS 42
342 ANAPHYLACTIC REACTION 42
343 BIPOLAR DISORDER 42
344 BRUXISM 42
345 DYSPHONIA 42
346 EUPHORIC MOOD 42
347 EXPOSURE VIA DIRECT CONTACT 42
348 MAJOR DEPRESSION 42
349 PRODUCT PRESCRIBING ERROR 42
350 BURNING SENSATION 41
351 DISEASE RECURRENCE 41
352 DYSARTHRIA 41
353 HAEMORRHAGE 41
354 INJURY 41
355 MENTAL STATUS CHANGES 41
356 NARCOLEPSY 41
357 SUBSTANCE USE DISORDER 41
358 TACHYPNOEA 41
359 THINKING ABNORMAL 41
360 CHOREOATHETOSIS 40
361 EATING DISORDER 40
362 EYE DISORDER 40
363 FEBRILE NEUTROPENIA 40
364 LIMB INJURY 40
365 MUSCLE CONTRACTURE 40
366 OBESITY 40
367 WHITE BLOOD CELL COUNT INCREASED 40
368 BEHAVIOUR DISORDER 39
369 EPILEPSY 39
370 EXPIRED DRUG ADMINISTERED 39
371 INTERVERTEBRAL DISC PROTRUSION 39
372 MITRAL VALVE INCOMPETENCE 39
373 OSTEOARTHRITIS 39
374 PHARMACEUTICAL PRODUCT COMPLAINT 39
375 PSORIASIS 39
376 THERAPY PARTIAL RESPONDER 39
377 THROMBOCYTOPENIA 39
378 UPPER RESPIRATORY TRACT INFECTION 39
379 ANKLE FRACTURE 38
380 APHASIA 38
381 DISSOCIATION 38
382 HOMICIDAL IDEATION 38
383 NEURALGIA 38
384 OEDEMA 38
385 RASH GENERALISED 38
386 SKIN DISCOLOURATION 38
387 AUTISM SPECTRUM DISORDER 37
388 FLUID RETENTION 37
389 HERPES ZOSTER 37
390 INFLUENZA LIKE ILLNESS 37
391 MUSCULOSKELETAL PAIN 37
392 PRODUCT PHYSICAL ISSUE 37
393 SUICIDAL BEHAVIOUR 37
394 BRAIN OEDEMA 36
395 CELLULITIS 36
396 COORDINATION ABNORMAL 36
397 DISABILITY 36
398 EYE IRRITATION 36
399 HYPOXIA 36
400 RASH ERYTHEMATOUS 36
401 RESPIRATORY DEPRESSION 36
402 STATUS EPILEPTICUS 36
403 THERAPY INTERRUPTED 36
404 THROAT IRRITATION 36
405 UNDERDOSE 36
406 BLISTER 35
407 BLOOD POTASSIUM DECREASED 35
408 EAR INFECTION 35
409 ERECTILE DYSFUNCTION 35
410 EYE PAIN 35
411 FEELING DRUNK 35
412 HEAD INJURY 35
413 HYPONATRAEMIA 35
414 ILL-DEFINED DISORDER 35
415 MYOCARDITIS 35
416 PALLOR 35
417 PRE-ECLAMPSIA 35
418 SALIVARY HYPERSECRETION 35
419 AFFECTIVE DISORDER 34
420 ANGIOEDEMA 34
421 APPLICATION SITE DISCOMFORT 34
422 DISEASE PROGRESSION 34
423 HEART RATE DECREASED 34
424 HYPOKINESIA 34
425 INSURANCE ISSUE 34
426 METABOLIC ACIDOSIS 34
427 OCULAR HYPERAEMIA 34
428 POST-TRAUMATIC STRESS DISORDER 34
429 REBOUND EFFECT 34
430 RETCHING 34
431 SOCIAL AVOIDANT BEHAVIOUR 34
432 ACCIDENTAL OVERDOSE 33
433 BRAIN FOG 33
434 CONTRAINDICATED PRODUCT ADMINISTERED 33
435 GROWTH RETARDATION 33
436 INCORRECT PRODUCT ADMINISTRATION DURATION 33
437 INFUSION RELATED REACTION 33
438 INTRACRANIAL PRESSURE INCREASED 33
439 ORAL HERPES 33
440 PERSONALITY CHANGE 33
441 STOMATITIS 33
442 BLOOD CREATININE INCREASED 32
443 CIRCULATORY COLLAPSE 32
444 GAIT INABILITY 32
445 HEPATIC STEATOSIS 32
446 JOINT SWELLING 32
447 OXYGEN SATURATION DECREASED 32
448 STEVENS-JOHNSON SYNDROME 32
449 APPLICATION SITE OEDEMA 31
450 BRADYPHRENIA 31
451 DRUG RESISTANCE 31
452 GASTRIC DISORDER 31
453 INCORRECT ROUTE OF DRUG ADMINISTRATION 31
454 INTENTIONAL DRUG MISUSE 31
455 RASH PRURITIC 31
456 RENAL IMPAIRMENT 31
457 RESPIRATORY DISTRESS 31
458 SNORING 31
459 THERAPEUTIC RESPONSE CHANGED 31
460 THROAT TIGHTNESS 31
461 IMPAIRED GASTRIC EMPTYING 30
462 IMPAIRED QUALITY OF LIFE 30
463 OPPOSITIONAL DEFIANT DISORDER 30
464 PRODUCT DISPENSING ERROR 30
465 PRODUCTIVE COUGH 30
466 RESPIRATORY DISORDER 30
467 ANHEDONIA 29
468 DERMAL ABSORPTION IMPAIRED 29
469 HYPOPHAGIA 29
470 IMPAIRED WORK ABILITY 29
471 LUNG CYST 29
472 NOCTURIA 29
473 RAYNAUD^S PHENOMENON 29
474 VIRAL INFECTION 29
475 DIPLOPIA 28
476 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 28
477 FEELING COLD 28
478 LIMB DISCOMFORT 28
479 LIP SWELLING 28
480 NEUROLEPTIC MALIGNANT SYNDROME 28
481 ORTHOSTATIC HYPOTENSION 28
482 PRODUCT USE COMPLAINT 28
483 SWOLLEN TONGUE 28
484 VITAMIN D DEFICIENCY 28
485 ATAXIA 27
486 BLOOD PRESSURE DECREASED 27
487 DISTRACTIBILITY 27
488 LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR 27
489 MALIGNANT NEOPLASM PROGRESSION 27
490 NEGATIVISM 27
491 PANCREATITIS 27
492 PLATELET COUNT DECREASED 27
493 PRODUCT DOSE OMISSION IN ERROR 27
494 PRODUCT FORMULATION ISSUE 27
495 SUSPECTED SUICIDE 27
496 THERAPEUTIC PRODUCT EFFECT VARIABLE 27
497 TOOTH DISORDER 27
498 ANAL INCONTINENCE 26
499 ARTHROPATHY 26
500 CARDIAC DISORDER 26
501 COLITIS 26
502 DEAFNESS 26
503 DRUG EFFECT INCOMPLETE 26
504 EXTRA DOSE ADMINISTERED 26
505 FEEDING DISORDER 26
506 IRRITABLE BOWEL SYNDROME 26
507 KOUNIS SYNDROME 26
508 MUSCLE TIGHTNESS 26
509 NYSTAGMUS 26
510 RECALLED PRODUCT ADMINISTERED 26
511 RIB FRACTURE 26
512 SENSORY DISTURBANCE 26
513 SKIN REACTION 26
514 SLEEP-RELATED EATING DISORDER 26
515 SLUGGISHNESS 26
516 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 26
517 APPLICATION SITE HYPERSENSITIVITY 25
518 APPLICATION SITE INFLAMMATION 25
519 BLOOD PRESSURE ABNORMAL 25
520 COLITIS ULCERATIVE 25
521 CYANOSIS 25
522 DYSPNOEA EXERTIONAL 25
523 FLATULENCE 25
524 GASTROENTERITIS VIRAL 25
525 HYPERPROLACTINAEMIA 25
526 IMPAIRED DRIVING ABILITY 25
527 MUSCLE RIGIDITY 25
528 MUSCULOSKELETAL DISCOMFORT 25
529 PANIC REACTION 25
530 PERIPHERAL COLDNESS 25
531 PHOTOSENSITIVITY REACTION 25
532 PRODUCT PACKAGING QUANTITY ISSUE 25
533 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 25
534 SEDATION COMPLICATION 25
535 SKIN DISORDER 25
536 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 25
537 ACTIVITIES OF DAILY LIVING IMPAIRED 24
538 ANGINA PECTORIS 24
539 APPLICATION SITE BRUISE 24
540 CONCUSSION 24
541 DEVICE PHYSICAL PROPERTY ISSUE 24
542 HAEMATOCHEZIA 24
543 HYPERTHERMIA 24
544 HYPOACUSIS 24
545 HYPOKALAEMIA 24
546 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 24
547 KIDNEY INFECTION 24
548 KNEE ARTHROPLASTY 24
549 LEUKOPENIA 24
550 NERVOUS SYSTEM DISORDER 24
551 PANCREATITIS ACUTE 24
552 PANCYTOPENIA 24
553 PRECOCIOUS PUBERTY 24
554 RESPIRATORY TRACT MALFORMATION 24
555 STAPHYLOCOCCAL INFECTION 24
556 TOOTH EXTRACTION 24
557 TYPE 2 DIABETES MELLITUS 24
558 VITILIGO 24
559 CATATONIA 23
560 CHOLECYSTECTOMY 23
561 CHOLELITHIASIS 23
562 DEVICE USE ERROR 23
563 DRUG LEVEL DECREASED 23
564 EYE MOVEMENT DISORDER 23
565 FOOD ALLERGY 23
566 GENERAL PHYSICAL HEALTH DETERIORATION 23
567 HANGOVER 23
568 HEAD DISCOMFORT 23
569 INJECTION SITE ERYTHEMA 23
570 LACRIMATION INCREASED 23
571 LACTIC ACIDOSIS 23
572 PRIAPISM 23
573 PRURITUS GENERALISED 23
574 PSORIATIC ARTHROPATHY 23
575 RESPIRATORY FAILURE 23
576 SINUS DISORDER 23
577 SKIN BURNING SENSATION 23
578 SPINAL OPERATION 23
579 WHEEZING 23
580 BACK INJURY 22
581 BREAST CANCER 22
582 COELIAC DISEASE 22
583 DECREASED EYE CONTACT 22
584 EXCESSIVE EYE BLINKING 22
585 EYE PRURITUS 22
586 GRAND MAL CONVULSION 22
587 HAEMOGLOBIN DECREASED 22
588 INJECTION SITE REACTION 22
589 KNEE OPERATION 22
590 LYMPHOCYTE COUNT DECREASED 22
591 MYCOBACTERIUM FORTUITUM INFECTION 22
592 PHOTOPHOBIA 22
593 PRESYNCOPE 22
594 SCHIZOPHRENIA 22
595 STRESS CARDIOMYOPATHY 22
596 VAGINAL HAEMORRHAGE 22
597 APPLICATION SITE WARMTH 21
598 ARTERIOSPASM CORONARY 21
599 BACK DISORDER 21
600 CARDIAC FAILURE 21
601 CHOLESTASIS 21
602 DECREASED INTEREST 21
603 DEPERSONALISATION/DEREALISATION DISORDER 21
604 DEVICE DEFECTIVE 21
605 DRUG SCREEN POSITIVE 21
606 DYSSTASIA 21
607 DYSURIA 21
608 ENDOTRACHEAL INTUBATION 21
609 EYE SWELLING 21
610 GLOSSODYNIA 21
611 HIP FRACTURE 21
612 HYSTERECTOMY 21
613 INJECTION SITE BRUISING 21
614 LYMPHOPENIA 21
615 MOTOR DYSFUNCTION 21
616 OBSESSIVE-COMPULSIVE SYMPTOM 21
617 ORAL PAIN 21
618 PRODUCT PRESCRIBING ISSUE 21
619 SELF-DESTRUCTIVE BEHAVIOUR 21
620 THERAPEUTIC PRODUCT EFFECT DELAYED 21
621 TRANSIENT ISCHAEMIC ATTACK 21
622 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 21
623 ABNORMAL LOSS OF WEIGHT 20
624 ABORTION SPONTANEOUS 20
625 APNOEA 20
626 APPETITE DISORDER 20
627 APPLICATION SITE HAEMORRHAGE 20
628 BLOOD GLUCOSE DECREASED 20
629 BLOOD PRESSURE FLUCTUATION 20
630 CARDIAC FAILURE CONGESTIVE 20
631 CROHN^S DISEASE 20
632 DENTAL CARIES 20
633 DERMATILLOMANIA 20
634 HAEMATURIA 20
635 HYPERPHAGIA 20
636 HYPOGLYCAEMIA 20
637 LACTATION DISORDER 20
638 LOWER LIMB FRACTURE 20
639 MYOCLONUS 20
640 OSTEOPOROSIS 20
641 SCIATICA 20
642 SELF-INJURIOUS IDEATION 20
643 SKIN LESION 20
644 WEIGHT GAIN POOR 20
645 ABNORMAL SLEEP-RELATED EVENT 19
646 ACUTE RESPIRATORY DISTRESS SYNDROME 19
647 APPLICATION SITE ULCER 19
648 BONE PAIN 19
649 CHANGE IN SUSTAINED ATTENTION 19
650 COMMUNICATION DISORDER 19
651 CORONARY ARTERY DISSECTION 19
652 CYSTITIS 19
653 DEVICE LEAKAGE 19
654 ELECTROCARDIOGRAM ABNORMAL 19
655 FORMICATION 19
656 GASTRITIS 19
657 HAEMATEMESIS 19
658 HALLUCINATIONS, MIXED 19
659 INCOHERENT 19
660 INCONTINENCE 19
661 INJECTION SITE PRURITUS 19
662 INTESTINAL OBSTRUCTION 19
663 LIGAMENT SPRAIN 19
664 LYMPHADENOPATHY 19
665 MYCOBACTERIAL PERITONITIS 19
666 PARASOMNIA 19
667 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 19
668 SCAR 19
669 SPLENIC INFARCTION 19
670 SUPRAVENTRICULAR TACHYCARDIA 19
671 TRICHOTILLOMANIA 19
672 VENTRICULAR TACHYCARDIA 19
673 CARDIOGENIC SHOCK 18
674 CHOKING 18
675 CLOSTRIDIUM DIFFICILE COLITIS 18
676 CLOSTRIDIUM DIFFICILE INFECTION 18
677 DEVICE MALFUNCTION 18
678 DEVICE RELATED INFECTION 18
679 DEVICE USE ISSUE 18
680 DRUG DISPENSING ERROR 18
681 ECONOMIC PROBLEM 18
682 END STAGE RENAL DISEASE 18
683 FRUSTRATION TOLERANCE DECREASED 18
684 FUNGAL INFECTION 18
685 HYPERTONIA 18
686 HYPERTONIC BLADDER 18
687 INFLAMMATION 18
688 JOINT INJURY 18
689 LOWER RESPIRATORY TRACT INFECTION 18
690 MICTURITION URGENCY 18
691 OBSTRUCTIVE SLEEP APNOEA SYNDROME 18
692 PETIT MAL EPILEPSY 18
693 PROCEDURAL PAIN 18
694 PRODUCT RESIDUE PRESENT 18
695 RASH MACULAR 18
696 RESPIRATORY TRACT INFECTION 18
697 SEPTIC SHOCK 18
698 SNEEZING 18
699 THYROID DISORDER 18
700 UPPER LIMB FRACTURE 18
701 VISUAL ACUITY REDUCED 18
702 BRAIN INJURY 17
703 BRONCHOSPASM 17
704 CARPAL TUNNEL SYNDROME 17
705 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 17
706 DECREASED ACTIVITY 17
707 DERMATITIS 17
708 DEVICE MECHANICAL ISSUE 17
709 HEART RATE IRREGULAR 17
710 HEAVY MENSTRUAL BLEEDING 17
711 HERNIA 17
712 HYPERGLYCAEMIA 17
713 HYPOMANIA 17
714 INJECTION SITE SWELLING 17
715 INTERVERTEBRAL DISC DEGENERATION 17
716 JOINT DISLOCATION 17
717 LEUKOCYTOSIS 17
718 MECHANICAL VENTILATION 17
719 MUSCLE SPASTICITY 17
720 PAIN IN JAW 17
721 PERSECUTORY DELUSION 17
722 PULMONARY HYPERTENSION 17
723 QUALITY OF LIFE DECREASED 17
724 RED BLOOD CELL COUNT DECREASED 17
725 SCRATCH 17
726 SINUS CONGESTION 17
727 SKIN HAEMORRHAGE 17
728 SLEEP PARALYSIS 17
729 SLEEP TALKING 17
730 STREPTOCOCCAL INFECTION 17
731 SYSTEMIC LUPUS ERYTHEMATOSUS 17
732 ACUTE HEPATIC FAILURE 16
733 ACUTE PSYCHOSIS 16
734 APPLICATION SITE BLEEDING 16
735 BACTERIAL INFECTION 16
736 CARDIOVASCULAR DISORDER 16
737 CENTRAL NERVOUS SYSTEM LESION 16
738 CEREBRAL HAEMORRHAGE 16
739 CONGESTIVE CARDIOMYOPATHY 16
740 DYSPHORIA 16
741 ENCEPHALOPATHY 16
742 HALLUCINATION, TACTILE 16
743 LARYNGITIS 16
744 MALNUTRITION 16
745 MENSTRUATION IRREGULAR 16
746 MIOSIS 16
747 PRODUCT PREPARATION ERROR 16
748 PSYCHIATRIC SYMPTOM 16
749 PULMONARY CONGESTION 16
750 RENAL INJURY 16
751 ROTATOR CUFF SYNDROME 16
752 SARS-COV-2 TEST POSITIVE 16
753 SEXUAL DYSFUNCTION 16
754 STARING 16
755 SUDDEN DEATH 16
756 TACHYPHRENIA 16
757 TEARFULNESS 16
758 TENDONITIS 16
759 TOOTHACHE 16
760 ABNORMAL WEIGHT GAIN 15
761 APPLICATION SITE LACERATION 15
762 AUTONOMIC NERVOUS SYSTEM IMBALANCE 15
763 BLADDER DISORDER 15
764 BLOOD ALKALINE PHOSPHATASE INCREASED 15
765 BLOOD IRON DECREASED 15
766 BLOOD PRESSURE SYSTOLIC INCREASED 15
767 CHOREA 15
768 CYST 15
769 DIVERTICULITIS 15
770 DYSPHEMIA 15
771 FREQUENT BOWEL MOVEMENTS 15
772 HAEMORRHOIDS 15
773 HYPERVENTILATION 15
774 IMMUNODEFICIENCY 15
775 INABILITY TO AFFORD MEDICATION 15
776 JOINT STIFFNESS 15
777 NERVE INJURY 15
778 OCULOGYRIC CRISIS 15
779 OVERWEIGHT 15
780 PARKINSON^S DISEASE 15
781 PLEURAL EFFUSION 15
782 POOR SUCKING REFLEX 15
783 PRESCRIPTION FORM TAMPERING 15
784 RESPIRATORY RATE INCREASED 15
785 SKIN LACERATION 15
786 STEREOTYPY 15
787 TOOTH FRACTURE 15
788 TOOTH INFECTION 15
789 ACUTE RESPIRATORY FAILURE 14
790 AMENORRHOEA 14
791 APHONIA 14
792 AUTOIMMUNE DISORDER 14
793 BLEPHAROSPASM 14
794 BLOOD UREA INCREASED 14
795 BUNDLE BRANCH BLOCK RIGHT 14
796 C-REACTIVE PROTEIN INCREASED 14
797 CEREBRAL INFARCTION 14
798 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 14
799 COLD SWEAT 14
800 DEPRESSIVE SYMPTOM 14
801 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 14
802 DRY THROAT 14
803 ECCHYMOSIS 14
804 GASTROENTERITIS 14
805 GLAUCOMA 14
806 HIGH RISK SEXUAL BEHAVIOUR 14
807 HOSTILITY 14
808 HYPERACUSIS 14
809 HYPERREFLEXIA 14
810 HYPOAESTHESIA ORAL 14
811 IMPULSE-CONTROL DISORDER 14
812 INCORRECT DOSE ADMINISTERED BY DEVICE 14
813 INTENTIONAL REMOVAL OF DRUG DELIVERY SYSTEM BY PATIENT 14
814 INTRUSIVE THOUGHTS 14
815 LOSS OF LIBIDO 14
816 LYME DISEASE 14
817 METABOLIC DISORDER 14
818 MUSCULOSKELETAL CHEST PAIN 14
819 NEEDLE ISSUE 14
820 OSTEOPENIA 14
821 PARADOXICAL DRUG REACTION 14
822 PLASMA CELL MYELOMA 14
823 POOR VENOUS ACCESS 14
824 POST PROCEDURAL COMPLICATION 14
825 PRESCRIBED UNDERDOSE 14
826 PRODUCT SUPPLY ISSUE 14
827 RASH PAPULAR 14
828 RESPIRATION ABNORMAL 14
829 SINUS BRADYCARDIA 14
830 SKIN FISSURES 14
831 SLEEP TERROR 14
832 SUBSTANCE USE 14
833 TONGUE BITING 14
834 TORTICOLLIS 14
835 TOURETTE^S DISORDER 14
836 ABDOMINAL PAIN LOWER 13
837 ABSCESS 13
838 APPLICATION SITE DERMATITIS 13
839 ASPIRATION 13
840 BEZOAR 13
841 BLINDNESS 13
842 BLOOD PRESSURE DIASTOLIC INCREASED 13
843 CARDIAC FAILURE ACUTE 13
844 DISSOCIATIVE DISORDER 13
845 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 13
846 EAR PAIN 13
847 GAMBLING DISORDER 13
848 HIATUS HERNIA 13
849 LIPOPROTEIN (A) INCREASED 13
850 LIVER DISORDER 13
851 LIVER INJURY 13
852 MOUTH ULCERATION 13
853 MULTIPLE ALLERGIES 13
854 MUSCULOSKELETAL DISORDER 13
855 NERVE COMPRESSION 13
856 OSTEOMYELITIS 13
857 PERFORMANCE STATUS DECREASED 13
858 PHARYNGEAL SWELLING 13
859 PHYSICAL ASSAULT 13
860 PREGNANCY 13
861 PREMATURE BABY 13
862 PRODUCT TASTE ABNORMAL 13
863 RADIUS FRACTURE 13
864 RENAL DISORDER 13
865 SHOULDER OPERATION 13
866 SLEEP DEFICIT 13
867 TERMINAL INSOMNIA 13
868 THERAPEUTIC PRODUCT EFFECT INCREASED 13
869 THERAPY CHANGE 13
870 TOOTH LOSS 13
871 UTERINE LEIOMYOMA 13
872 VITAMIN D DECREASED 13
873 ACCIDENT 12
874 APPENDICITIS 12
875 APPLICATION SITE PAPULES 12
876 AUTOIMMUNE THYROIDITIS 12
877 BLOOD PRESSURE DIASTOLIC ABNORMAL 12
878 BLOOD PRESSURE SYSTOLIC ABNORMAL 12
879 CANDIDA INFECTION 12
880 CHRONIC FATIGUE SYNDROME 12
881 CLUMSINESS 12
882 DAYDREAMING 12
883 DEFIANT BEHAVIOUR 12
884 EAR DISCOMFORT 12
885 ENDOMETRIOSIS 12
886 ENERGY INCREASED 12
887 ERUCTATION 12
888 EXOSTOSIS 12
889 GALACTORRHOEA 12
890 GLUCOSE TOLERANCE IMPAIRED 12
891 HAEMATOCRIT DECREASED 12
892 IMPAIRED HEALING 12
893 INCORRECT DOSE ADMINISTERED BY PRODUCT 12
894 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 12
895 INFUSION SITE PAIN 12
896 IRON DEFICIENCY 12
897 LARGE INTESTINE POLYP 12
898 LIP DRY 12
899 LIVEDO RETICULARIS 12
900 MITRAL VALVE PROLAPSE 12
901 MULTIPLE DRUG OVERDOSE 12
902 MUTISM 12
903 NASAL SEPTUM DEVIATION 12
904 NEOPLASM PROGRESSION 12
905 NEUTROPHIL COUNT INCREASED 12
906 OROMANDIBULAR DYSTONIA 12
907 PARTIAL SEIZURES 12
908 PERICARDIAL EFFUSION 12
909 PERICARDITIS 12
910 PETECHIAE 12
911 PNEUMONITIS 12
912 POST PROCEDURAL INFECTION 12
913 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 12
914 PRODUCT COMMUNICATION ISSUE 12
915 PRODUCT COMPLAINT 12
916 PRODUCT ODOUR ABNORMAL 12
917 REDUCED FACIAL EXPRESSION 12
918 ROSACEA 12
919 SCOLIOSIS 12
920 SEXUALLY INAPPROPRIATE BEHAVIOUR 12
921 SYDENHAM^S CHOREA 12
922 TRANSAMINASES INCREASED 12
923 TUBULOINTERSTITIAL NEPHRITIS 12
924 VENTRICULAR EXTRASYSTOLES 12
925 VENTRICULAR FIBRILLATION 12
926 VITAMIN B12 DEFICIENCY 12
927 WISDOM TEETH REMOVAL 12
928 WOUND 12
929 ABASIA 11
930 ANAPHYLACTIC SHOCK 11
931 APLASTIC ANAEMIA 11
932 ASPHYXIA 11
933 ATRIAL SEPTAL DEFECT 11
934 BLOOD BILIRUBIN INCREASED 11
935 BLOOD URINE PRESENT 11
936 BONE DENSITY DECREASED 11
937 BRADYPNOEA 11
938 COMA SCALE ABNORMAL 11
939 CYSTIC FIBROSIS 11
940 DEPENDENCE 11
941 DRUG DELIVERY SYSTEM ISSUE 11
942 DYSMENORRHOEA 11
943 ELECTROLYTE IMBALANCE 11
944 FACIAL PARALYSIS 11
945 FOOT DEFORMITY 11
946 GASTROINTESTINAL HAEMORRHAGE 11
947 GLUTEN SENSITIVITY 11
948 HEMIPARESIS 11
949 HEPATIC ENCEPHALOPATHY 11
950 HEPATIC FAILURE 11
951 HEPATOMEGALY 11
952 HYPERAESTHESIA 11
953 HYPERAMMONAEMIA 11
954 HYPERLIPIDAEMIA 11
955 INSULIN RESISTANCE 11
956 KERATOCONUS 11
957 LABORATORY TEST ABNORMAL 11
958 LIBIDO DECREASED 11
959 LUNG DISORDER 11
960 MALIGNANT MELANOMA 11
961 MENORRHAGIA 11
962 MUSCLE CONTRACTIONS INVOLUNTARY 11
963 NEOPLASM MALIGNANT 11
964 NO THERAPEUTIC RESPONSE 11
965 OCULAR DISCOMFORT 11
966 PARALYSIS 11
967 PERITONITIS BACTERIAL 11
968 POISONING DELIBERATE 11
969 POOR QUALITY DEVICE USED 11
970 PRODUCT PACKAGING ISSUE 11
971 PSYCHOLOGICAL TRAUMA 11
972 RASH MACULO-PAPULAR 11
973 SENSATION OF FOREIGN BODY 11
974 SKIN ABRASION 11
975 SKIN WOUND 11
976 SPINAL OSTEOARTHRITIS 11
977 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 11
978 ULCER 11
979 URTICARIA GENERALISED 11
980 ADRENAL INSUFFICIENCY 10
981 ARTHROPOD BITE 10
982 BLOOD SODIUM DECREASED 10
983 BLOOD SODIUM INCREASED 10
984 BLOOD TRIGLYCERIDES INCREASED 10
985 BRAIN DEATH 10
986 BREAST MASS 10
987 BURSITIS 10
988 CAESAREAN SECTION 10
989 CARDIOMYOPATHY 10
990 CORONARY ARTERY OCCLUSION 10
991 CRANIOCEREBRAL INJURY 10
992 DERMATITIS ALLERGIC 10
993 DIZZINESS POSTURAL 10
994 EXPOSURE VIA SKIN CONTACT 10
995 FAECES DISCOLOURED 10
996 FEELING OF DESPAIR 10
997 FLANK PAIN 10
998 FOOD CRAVING 10
999 FOOT OPERATION 10